Novo Holdings A/S 3
3 · MapLight Therapeutics, Inc. · Filed Oct 27, 2025
Insider Transaction Report
Form 3
Novo A/S
10% Owner
Holdings
Series C Preferred Stock
→ Voting Common Stock (1,558,999 underlying)Series D Preferred Stock
→ Voting Common Stock (1,174,682 underlying)
Footnotes (1)
- [F1]The Series C Preferred Stock and Series D Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.